-
+10 +1
The Neurological Exam Explained
Stephanie explains what your neurologist is doing during the neurological exam.
-
+2 +1
Safety Alerts for Human Medical Products > Gilenya (fingolimod) - FDA Warns About Cases of Rare Brain Infection
Heads-up from the FDA - Cases of progressive multifocal leukoencephalopathy (PML) in two patients with no prior exposure to immunosuppressant drugs. ...and the stock price of Novartis is temporarily doomed.
-
+19 +1
Why Did My Grandmother Try LSD For Multiple Sclerosis In The 1960s?
And why would it be so hard for someone like her to do that today?
-
+22 +1
Genetics' Contribution To Multiple Sclerosis Risk Among Ashkenazi Jews Investigated
Multiple sclerosis (MS) has a strong genetic component, with high MS prevalence in European populations including those of Ashkenazi Jewish origin, and low in African and Asian populations also including those of Jewish origin
-
+16 +1
Multiple Sclerosis Research: poor recovery from relapses predict progression
This is exactly the sort of post neurologists and MS specialist nurses should read.
-
+2 +1
Multiple sclerosis sufferer sues police for 'mistaking him for a drunk'
This takes the "I'm not drunk, I have MS" saying to another level.
-
+2 +1
Multiple Sclerosis FAQs
Discover more about Multiple Sclerosis.
-
+12 +1
Scientists ID Cause of Movement, Balance Problems in Multiple Sclerosis
A newly arrived faculty member is part of a research team that found a faulty “brake” within immune cells that may cause many of the symptoms of MS.
-
+2 +1
Canadian Pediatric Demyelinating Disease Network Funding To Help Expand Multiple Sclerosis Research
Canadian Pediatric Demyelinating Disease Network gets boost with $3.2 million grant funding to help expand pediatric multiple sclerosis research
-
+1 +1
MSPrecise Shown to be Accurate in Diagnosing RRMS in Study Cohort
The test accurately diagnosed 84% of multiple sclerosis patients from a broad range of subjects with potential neurological diseases.
-
+1 +1
Altered Immune Cells in Relapsing Remitting Multiple Sclerosis Patients Cause Reduced Immune Capacity
Here authors investigated how polymorphonuclear cells functions, important players of the innate immune system, are altered in multiple sclerosis patients.
-
+1 +1
How many multiple sclerosis patients are in the U.S.? No one knows.
Bruce Bebo, executive vice president of research at the National MS Society, says the organization’s estimate of about 400,000 patients in the U.S. is based on epidemiology-based population estimated developed in the 1970s.
-
+18 +1
The monster under the bed
"What’s the thing you’re most scared MS will do to you?" A heartfelt answer to a a 6-year-old's question.
-
+2 +1
Multiple Sclerosis Research: MS Basics - SPASTICITY
I promised to post on spasticity in MS a while back. Hope you find this post useful...
-
+1 +1
Masitinib Shows Promise in Early Study For Treating Progressive MS Patients
Progressive multiple sclerosis patients treated with AB Science’s lead compound AB07002 (masitinib) in a Phase 3 clinical trial showed positive results in a non futility test
-
+2 +1
Biogen's Tecfidera Now The Most Prescribed Oral MS Therapy Globally
Cambridge, Massachusetts based Biogen Inc. has reported its second quarter 2015 results, posting a year-over-year seven percent revenue increase to $2.6 Billion in the quarter.
-
+14 +1
Multiple sclerosis breakthrough: Scientists develop technology to assist doctors in detection of brain lesions
One of these lesions is not like the others.
-
+2 +1
In sickness and in help
My husband is learning to live with his MS, thanks to the American Disabilities Act and because of my own personal history with medical adversity.
-
+1 +1
Biogen Shares Plunge 22% on Poor MS Drug Performance, Slashed Outlook
Revised outlook attributed to lower Tecfidera demand
-
+4
Why /t/multiplesclerosis?
2 comments by trails
Submit a link
Start a discussion